Directory · DK
Pharmaceutical Manufacturing in Denmark
A register of firms and the professionals working at them in the Pharmaceutical Manufacturing sector based in Denmark. Browse the public index, then filter or export on Kipplo.
Companies
218 on file
J-Star Research, Inc
J-STAR Research, Inc. is a contract chemistry organization serving as an outsourcing partner for the pharmaceutical and biotechnology industries. J-STAR is a leading provider of services in organic synthesis problem solving, early phase non-GMP and GMP manufacturing and crystallization R&D. While high quality synthetic chemistry and process research services continue to be J-Star’s foundation, the company has steadily added and continues to expand in the areas of QC, GMP and QA, Crystallization R&D, Solid Form and Polymorph Screening, Catalysis Screening + Enabling Technology, Highly Potent Compound Handling (HPAPI), Impurity Isolation and Structural Elucidation by NMR and HR-LC/MS and Preformulation for Drug Product Development. J-Star’s expert team of scientists and professionals coupled with solid industrial experience, a track record of dependability, and over SF of well-equipped laboratories across two New Jersey research facilities ensures that all projects are delivered in full, on time and with rigorous quality.
51 to 200 staff
Lundbeck
Lundbeck is a biopharmaceutical company focusing exclusively on brain health. With more than 70 years of experience in neuroscience, we are committed to improving the lives of people with neurological and psychiatric diseases. Brain disorders affect a large part of the world’s population, and the effects are felt throughout society. With the rapidly improving understanding of the biology of the brain, we hold ourselves accountable for advancing brain health by curiously exploring new opportunities for treatments. As a focused innovator, we strive for our research and development programs to tackle some of the most complex neurological challenges. We develop transformative medicines targeting people for whom there are few or no treatments available, expanding into neuro-specialty and neuro-rare from our strong legacy within psychiatry and neurology. We are committed to fighting stigma and we act to improve health equity. We strive to create long term value for our shareholders by making a positive contribution to patients, their families and society as a whole. Lundbeck has more than employees in more than 20 countries and our products are available in more than 80 countries. For additional information, we encourage you to visit our corporate site
5001 to 10000 staff
Novo Nordisk
We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: For other customer complaints, please contact us here: Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here:
10001+ staff
Aj Vaccines
About us From our headquarters in Copenhagen, we develop and manufacture vaccines, diagnostics, and therapeutic solutions for the world. We are 500 colleagues, and we pride ourselves on being a diverse workforce with passports from 39 nationalities. Being part of AJ Vaccines means joining a common mission towards a healthier and safer world. Whether you're an experienced professional or an emerging talent, you'll find a platform here to contribute, innovate, and create meaningful change. Om os Fra vores hovedkvarter i hjertet af København udvikler og producerer vi vacciner, diagnostiske værktøjer og terapeutiske løsninger med globalt formål. Vores mangfoldige arbejdsstyrke består af 500 dedikerede kolleger og omfavner 39 forskellige nationaliteter. Når du træder ind i AJ Vaccines, bliver du en aktiv del af en fælles mission, der stræber efter en sundere, global verden. Uanset om du er en erfaren professionel eller et spirende talent, vil du her finde en platform, hvor du kan udleve dine ambitioner, præge fremtiden og skabe resultater. Så kom og bliv en del af vores rejse – dit bidrag vil gøre en forskel!
501 to 1000 staff
Klifo
KLIFO is a drug development consultancy and full-service Clinical Trial Supply with significant experience in partnering with pharmaceutical and biotech companies. We enable our partners to maximise opportunity, mitigate risks, drive innovation and achieve efficient project advancement. We offer end to end solutions across all drug development areas, including strategic project management, regulatory affairs, clinical development, clinical trial supply, quality assurance (QA), Chemistry Manufacturing and Controls (CMC) development, non-clinical development and pharmacovigilance in relation to the development of pharmaceutical products. We provide strategic advice as well as operational support in all these areas, and we partner with clients on portfolio strategies, project development strategies and project execution. KLIFO has offices in Denmark and Sweden and employs more than 130 highly skilled experts.
51 to 200 staff
Missionpharma
Missionpharma is a leading supplier of generic pharmaceuticals, medical consumables, hospital equipment and medical kits to public and private institutions, international development organisations and the UN. Follow #missionforbetterhealth for updates We have offices Denmark, India and China and we employ 150 people worldwide. Our head office is based in Denmark from where our overall activities are managed. Missionpharma is a part of CFAO Healthcare - the healthcare division of the CFAO Group - a major distributor of international brands in Africa.
51 to 200 staff
Saniona
Saniona is a clinical-stage biopharmaceutical company leading the way in ion channel modulation for the treatment of epilepsy and other neurological disorders. Saniona’s epilepsy pipeline features SAN711, a Phase 2-ready candidate drug targeting absence seizures, SAN2219 for acute repetitive seizures, and SAN2355, addressing refractory focal onset seizures. Beyond epilepsy, Saniona oversees four clinical programs poised for collaboration. Tesofensine, Saniona’s most advanced candidate, is progressing towards regulatory approval for obesity in Mexico through a partnership with Medix. Tesomet™ is ready for Phase 2b, targeting rare eating disorders, while SAN903 is ready for Phase 1 for inflammatory bowel disease and SAN2465 is set for preclinical development for major depressive disorder. Saniona has esteemed partners, including Boehringer Ingelheim GmbH, Productos Medix, S.A de S.V, AstronauTx Limited, and Cephagenix ApS. Saniona is based in Copenhagen and listed on Nasdaq Stockholm Main Market. For more information, please visit (OMX: SANION).
11 to 50 staff
Leo Pharma Us
LEO Pharma is a global company dedicated to advancing the standard of care for the benefit of people with skin conditions, their families and society. Founded in 1908 and majority owned by the LEO Foundation, LEO Pharma has devoted decades of research and development to advance the science of dermatology, and today, the company offers a wide range of therapies for all disease severities. For more information, visit and follow us on Twitter @LEOPharmaUS. Disclaimer: This site is intended for discussions about LEO Pharma US and the various initiatives LEO Pharma US is involved in. Due to regulations, discussions about pharmaceutical products are not allowed on this channel. All content must be factual and non-promotional. LEO Pharma US reserves the right to moderate or remove any content that may be inconsistent with legislation, industry ethics and regulations and LEO Pharma US’ values, including- Profane or vulgar language - Insulting or offensive comments, such as displays of racism, calls to violence, hate propaganda, etc- Commercial or political advertising - Copyright infringements, or any violation of the rights of external parties - automatically-generated content i.e. spam - Wrong/false statements For more information about our social media principles, please visit https://leo-pharma.com/social-media-principles To view our privacy policy, go to
5001 to 10000 staff
Productlife Group
ProductLife Group (PLG) is a global service provider in Life Sciences, delivering end-to-end consulting and outsourcing services across the entire product lifecycle. With a presence in 150+ countries, own resources in 50+ countries, and a team of over professionals, PLG acts as a one-stop-shop partner for the pharmaceutical, biotechnology, medical device, nutrition, and cosmetics sectors. Our mission is to support clients in accelerating innovation, ensuring compliance, and ultimately improving human health. From Product Development to Market & Patient Access, from Regulatory Affairs and Safety & Vigilance to Consulting & Digital, our global experts join forces to shape the future of PLG’s client offering across multiple domains, including Biopharma industries, Consumer Healthcare, and Medical Devices. With a goal of continuously improving the value delivered to people and customers, PLG is committed to long-term partnership, innovation, flexibility, and cost efficiency.
1001 to 5000 staff
Syntese, A Ferring Company
Syntese A/S is a part of a Ferring Group and we are a word-leading manufacturer of 5-aminosalicylic acid - Mesalazine. It is an Active Pharmaceutical Ingredient used by the pharmaceutical industry in formulations for a treatment of Inflammatory Bowel Diseases (IBD) i.e. Ulcerative Colitis, Crohns Disease. Syntese has developed its own manufacturing method (chemical synthesis) of 5-ASA and implemented it for full-scale production in compliance with cGMP. Today Mesalazine is manufactured in multi-tons per year in the company’s highly automated production facility in Hvidovre, industrial outskirts of Copenhagen. Having more than 30 years experience in product- and process development Syntese guarantees its customers not only product of the highest quality but also an extensive R&D support and comprehensive regulatory compliance. Syntese carries Certificate of Suitability; European DMF; Canadian DMF; US DMF and is FDA approved. Company’s focus on safety and environment is expressed in Annual Environmental Reports and received County Environmental Award.
51 to 200 staff
Clinigma
Patients should be meaningfully involved throughout the medical product development process – as partners who are experts in their own experience of their disease or condition and the ultimate consumers of medical products. Recent guidance issued by the US Food and Drug Administration (FDA) recognises that the collection of patient experience data is important because it provides an opportunity to inform medical product development and enhance regulatory decision-making to better address patients’ needs. Who we are Clinigma®, previously known under the name Clinical Survey Outcomes, has the expertise to assist pharmaceutical companies who wish to comply with the FDA’s advice on how to collect and submit data. Our team of qualitative researchers are highly-skilled at capturing comprehensive and representative patient input and synthesising this feedback into relevant insights in a way that can inform the development process. How we work We achieve this by conducting in-depth interviews with patients participating in clinical trials (entry/exit interviews) and setting up tailormade questionnaires in relation to clinical trials (entry/exit interviews). The outcomes of our research can be used to get a better picture of the patients in the trial, to remove uncertainties surrounding the product profile, improve the outcomes strategy, sharpen marketing efforts and most important to have the answers ready when FDA asks for patients experience data. Clinigma® also provides qualitative research work in real-world settings and has access to one of the strongest patient, physician and key opinion leader (KOL) panels in the industry. Our real-world research work is often conducted to support our clients in showing the important relation between patient experiences in random clinical trials (RCTs) and real life. Our vision is to bring clarity and value to the pharmaceutical companies we work with by being their trial patients´ structured voice.
11 to 50 staff
Zpd A S
Joint pain from osteoarthritis is a very common disorder. We want to give humans and animals a better life. A life without joint pain, that gives the desire to move, dance and just enjoy life. At ZPD, we extract Chondroitin Sulfate under the highest standards, as our goal is to improve the efficacy and safety in products for humans and animals. By staying in front of development and manufacturing of mucopolysaccharides in cooperation with dedicated professionals and organizations, we continuously strive to improving quality of life for a world ageing population. We are confident in our ability to create a better business for our customer through customized and committed solutions. For 2 decades ZPD A/S has been a leading innovator in the manufacturing and development of glycosaminoglycan Chondroitin Sulfate sodium. Today each employee are contributing to create a sustainable environment and with high ethical standards. “Our goal is to continuously strive to create more sustainable, safe and available solutions that benefits an ageing world population. People worldwide are living longer and as our mission, we are committed to our belief that only through dedication and commitment can we contribute to create an ingredient that helps patients with osteoarthritis” Or simply: We are here to help
11 to 50 staff
Apotekeren
APOTEKEREN er landets ældste og største frivillige apotekerkæde. Formålet med kæden er at optimere og opnå stordriftsfordele inden for markedsføring, indkøb, uddannelse, dosispakning og meget mere. APOTEKEREN understøtter kontinuerligt medlemmerne i at have kunden i centrum og i at være forretningsmæssigt ledende ved at tilbyde relevante værktøjer. Vores opgave i APOTEKEREN er til stadighed at skabe merværdi samt at optimere service og information over for kunder, personale og medlemmer. Det gør vi ud fra værdierne: Tillid • Viden • Kvalitet • Økonomisk optimering Med afsæt i værdierne skaber vi resultater for det enkelte apotek og for kæden.
1 to 10 staff
Biograil
Biograil™ is a pre-clinical stage pharmaceutical company leveraging its proprietary BIONDD™ technology to unlock the potential of transforming the tremendous market of injectable pharmaceutical products into convenient oral capsules. We strive to make the most effective and convenient pharmaceuticals to patients in innovative and prioprietary ways by combining known technologies.
11 to 50 staff
Stada Nordic
As STADA, STADA Nordic fundamentally care for people’s health as a trusted partner. In pursuit of this purpose, we are committed to further accelerating the successful trajectory of our company. STADA is a leading manufacturer of high-quality pharmaceuticals. With a long-standing heritage rooted in pharmacies, we are perceived as a reliable and trustworthy partner for more than 120 years. With our products we help people protect and regain a dignified and able life. With our proven Generics, we ensure that everyday health remains affordable. To our employees, we offer an attractive working environment in which they can develop personally. Our branded products such as DERMALOG, Nizoral, Marplus, Hirudoid etc. are recognized by many in the Nordic region.
11 to 50 staff
Webapoteket
Webapoteket er et dansk onlineapotek, hvor du nemt, hurtigt og sikkert kan købe håndkøbsmedicin og andre apoteksrelaterede varer.
11 to 50 staff
Macure
Macure Group is an international, privately owned specialty pharmaceutical company headquartered in Copenhagen, Denmark. Since our founding in 2013, we have grown into a leading player in the Nordic market and beyond, with commercial sales in +25 countries and a direct presence across Western Europe. We specialize in delivering high-quality, niche pharmaceuticals that address unmet medical needs. Our expertise covers a wide range of therapeutic areas, and our flexible model allows us to bring meaningful treatments to patients efficiently and reliably. At Macure, partnerships are at the heart of our growth. We are actively looking to- In-license specialty generic pharmaceuticals for the EU & UK - Acquire global or regional rights to established medicines from originator companies - Collaborate with international partners to market specialty pharmaceuticals in Europe With a strong track record of acquisitions from major pharma companies in both Europe and the US, we are constantly expanding our portfolio to better serve patients and partners. Learn more at
11 to 50 staff
Sanos Group
Sanos Group is a Full Circle Clinical Research & Development Organization encompassing five independent business units: NBCD, Sanos Clinic, Sanos Supply, Studies & Me and Blueskin. Every division within the Sanos Group is committed to delivering top-tier clinical research, constantly enhancing our approach to pioneering innovative clinical trials for both clients and patients.
201 to 500 staff
Anodyne Danmark
Anodyne er europæisk producent og distributør af det originale holdningskorrigerende tøj til mænd og kvinder fra Amerikanske AlignMed. Vores produkter er som de eneste i europa registeret som medicinsk udstyr, hvorfor de er at finde på listen over godkendte hjælpemidler. Holdningskorrigerende tøj fra Anodyne virker ved at aktivere rygmuskulatur og skuldre uden at pacificere og fastlåse muskler eller led. Teknologien bag holdningskorrigerende tøj er derfor inspireret af kinesiotape – en behandlingsform der ofte anvendes af fysioterapeuter og kiropraktorer til at behandle smerter og spændinger i nakke, skuldre og ryg. Holdningskorrigerende tøj fra Anodyne® kan anvendes af alle og på alle tænklige tidspunkter - f.eks på kontoret, til sportslige aktiviteter, fysisk arbejde, eller under afslapning. Vi forhandler holdningskorrigerende t-shirts, BH’er, veste og seler, der alle er udviklet til at hjælpe med at aktivere muskulaturen og øge blodcirkulationen, og derved minde kroppen om at indtage en mere optimal holdning.
11 to 50 staff
Epione Medicine
Epione Medicine supplies medicine to the Danish Healthcare System. We provide high quality medicine at a lower cost, which contributes to the consumers wellbeing and less healthcare expenses for the society. This contribution is our license to operate. Our products are parallel imported from certified wholesalers in EU countries and are sold in Denmark under the same conditions as the original manufactures. Epione Medicine follows the Good Distribution Practice guideline (GDP), which assures that high quality is retained throughout the Supply Chain.
11 to 50 staff
Grenaa Apotek
Grenaa Apotek er et moderne og initiativrigt apotek beliggende midt i Grenaa by, drevet af Apoteker Lars F. Nørgaard. På apoteket er der 2 farmaceuter, 12 farmakonomer, 2 farmakonomelever samt 7 servicemedarbejdere Det første apotek i Grenaa blev grundlagt i 1744 under Apoteker August Ludvig Steube og er dermed det 37'ende apotek i Danmark. Apoteket har siden været lukket ned, genåbnet og flyttet placering 4 gange. Sidste gang fra Østergade til Kannikegade af Apoteker Lene Hübertz. Siden hen er apoteket blev overtaget af Lars F. Nørgaard i oktober 2014. Der hører 9 håndkøbsudsalg til apoteket, hvor der kan afhentes medicin. Disse befinder sig i Glesborg, Bønnerup, Trustrup, Ørum, Fjellerup, Voldby, Anholt, Gjerrild og Lyngby Se adresserne her. Derudover leveres også varer til kunder i Grenaa by (potnummer 8500).
11 to 50 staff
Jakob And Partners
Jakob and Partners is a global consulting firm, researching global market trends and performing high-value analyses of the pharmaceutical and biotech markets. We provide unbiased research and evidence-based analysis to support business decisions, and end-to-end comprehensive solutions that improve overall performance.
51 to 200 staff
Sandoz Danmark
Sandoz er en global leder inden for biosimilære- og generiske lægemidler. Det betyder, at når et patent er udløbet, udvikler vi biosimilære- og generiske lægemidler til en overkommelig pris og kan tilbyde medicin af høj kvalitet til flere mennesker verden over. Vores brede globale portefølje omfatter omkring 1.500 biosimilære- og generiske lægemidler. Disse bidrager til at forbedre sundheden for cirka en halv milliard patienter rundt om i verden. Vores vision er, at alle skal have adgang til den bedst mulige behandling. Et bedre og længere liv for flere mennesker. Det er derfor, Sandoz eksisterer. Community Guidelines: Privatlivspolitik for LinkedIn: NR2312185091 12/2023
51 to 200 staff
Abacus Medicine
Abacus Medicine buys and sells original, prescription medicine across borders. Our business model is based on the core principle of the free movement of goods in the EU’s single market. We pursue an ambitious, international growth strategy. We supply a large and growing number of pharmaceuticals to customers in many different markets and have a strategic focus and a strong position in the most expensive types of medicines, such as chemotherapies for cancer treatment or immunosuppressive drugs used in connection with organ transplants. Our ability to deliver on this strategy is rooted in our strong sourcing network and industry leading capabilities in complex data analysis. Our proven growth platform in Parallel Trade can be leveraged in two related, global industries: Supply for Clinical Trials and Unlicensed Medicines. Our early phase initiatives in these two market segments are conducted under the brand name Abacus Medicine Pharma Services. Established in 2004 by CEO Flemming Wagner and Medical Director John Wagner, Abacus Medicine has experienced significant growth ever since. Today, we are more than 1,300 colleagues in Europe and beyond.
1001 to 5000 staff
